FDA Approves Johnson & Johnson’s Pulsed Field Ablation Platform for AFib
The single-device solution combines pulsed field ablation therapy and advanced mapping for treating drug-refractory paroxysmal atrial fibrillation.
The single-device solution combines pulsed field ablation therapy and advanced mapping for treating drug-refractory paroxysmal atrial fibrillation.
ZMA001, in development for pulmonary arterial hypertension, has been designated as an Orphan Drug by the US Food and Drug Administration.
Inter-atrial shunts may be beneficial to heart failure patients with reduced left ventricular ejection fraction (LVEF) but harmful or even deadly for heart failure patients with preserved LVEF, a new Mount Sinai-led study shows.
Read MoreA study by UT Southwestern Medical Center has demonstrated that a combination of FDA-approved drugs can effectively regenerate damaged heart muscle.
Read MoreThe vest has 256 sensors rather than the 12 used in a standard electrocardiogram and can provide detailed electrical mapping of the heart in just five minutes.
Read MoreA beta blocker typically used to treat heart problems, hemangioma, migraines, and anxiety could be a new therapeutic for patients with sickle cell disease.
Read MoreWomen with atrial fibrillation undergoing a procedure called pulsed field ablation have just as good outcomes as men, a new study finds.
Read MoreThe US Food and Drug Administration approved Medtronic’s Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
Read MoreAged black garlic supplementation reduced blood pressure in a grade I hypertensive patients already taking blood-pressure reducing medications.
Read MoreDeep sleep—known for being crucial for overall health—is of particular benefit to the cardiovascular system, new research suggests.
Read MoreIn a new study, etripamil restored heart rate to normal within 30 minutes in 60.2% of the 188 verified paroxysmal supraventricular tachycardia episodes.
Read More